On September 30, 2022, Bausch Health Companies Inc. (BHCI) completed its $7.6 billion (US$5.6 billion) multi-pronged debt financing and liability management transactions that followed the initial public offering (IPO) of its subsidiary Bausch + Lomb Corporation (B+L) on the TSX and NYSE in May 2022.

Norton Rose Fulbright acted as counsel to BHCI with team that included Peter Wiazowski, Derek Chiasson, Christopher Horte, Heidi Reinhart, Thomas Nichols, Pierre-François Tétreault, Emile Berzghal, Stefanie Thibert and Chen Li.

White + Case acted as US counsel to BHCI. 

Blakes and Cahill Gordon acted as Canadian and US counsel, respectively, to Houlihan Lokey, as dealer-manager, on the exchange offers. 

Akin Gump acted as US counsel to certain supporting noteholders on the exchange offer.